[Damage due to treatment of psoriasis with folic acid antagonists].
D000747:Anemia, Hypochromic / Q000139:chemically induced*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002869:Chromosome Aberrations / Q000139:chemically induced; D025063:Chromosome Disorders; D003875:Drug Eruptions / Q000209:etiology; D005493:Folic Acid Antagonists / Q000009:adverse effects*; D006261:Headache / Q000139:chemically induced; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects*; D009059:Mouth Diseases / Q000139:chemically induced; D009061:Mouth Mucosa; D009325:Nausea / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy*; D014717:Vertigo / Q000139:chemically induced
D005493:Folic Acid Antagonists; D002955:Leucovorin; D008727:Methotrexate
Sui danni della terapia con antifolici nella psoriasi.